Podcast


Presenter: G. Michael Allan MD CCFP James McCormack BSc (Pharm) Pharm D Michael Kolber BSc MD CCFP MSc Tony Nickonchuk BScPharm CDE APA

Podcast: BS Medicine Episode #490: Opening a can of helminths: Ivermectin for COVID-19
0:00

In episode 490, Mike and James invite Tony and Mike to go over the best available evidence for ivermectin. Overall the evidence shows that ivermectin does not improve clinically important outcomes. Unfortunately, much of the evidence for ivermectin is unpublished and some has even been retracted. Show Notes Tools for Practice Opening a can of helminths:…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

BS Medicine Episode #587: Mission Slimpossible – Oral GLP-1 agonists for weight loss

In episode 587, Mike and James invite Adrienne Lindblad back to the podcast to go over all the evidence we have for the oral GLP-1 weight loss medications. You know…
Listen 0.5 credits available

CFP Podcast: Perennial post-examination surprises

As a family medicine teacher or Program Director, have you ever had a highly capable resident learner fail the Simulated Office Oral (SOO) portion of the CCFP examination? Have you…
Listen 0.5 credits available

BS Medicine Episode #586: It’s time to challenge penicillin allergy labels

In episode 586, Mike and James invite Émélie Braschi back to the podcast to talk about the tricky issue of how to deal with a potential penicillin allergy. Believe it…
Listen 0.5 credits available

Presenter(s):

G. Michael Allan MD CCFP James McCormack BSc (Pharm) Pharm D Michael Kolber BSc MD CCFP MSc Tony Nickonchuk BScPharm CDE APA

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • G. Michael Allan MD CCFP
  • James McCormack BSc (Pharm) Pharm D
  • Michael Kolber BSc MD CCFP MSc
  • Tony Nickonchuk BScPharm CDE APA

Spearkers do not have any conflicts of interest to declare.